This is a routine scheduling notice with no trading implications. Monitor the upcoming proxy statement for any shareholder proposals or governance changes, but no immediate action is warranted.
PDSB drugs
PDSB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 15 $1.02entry
- T+1 · 5mo ago −5.88%α −5.29% · $0.9600
- T+5 · 5mo ago −7.73%α −6.34% · $0.9412
- T+20 · 4mo ago −26.94%α −26.19% · $0.7452
- T+60 · 2mo ago −71.27%α −72.28% · $0.2930
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
PDS Biotechnology Corp filed an 8-K to announce that its 2026 Annual Meeting of Stockholders is scheduled for August 10, 2026, and set a June 25, 2026 deadline for stockholder proposals under Rule 14a-8. This is a routine administrative filing with no material financial or operational impact.
Key Facts
- 2026 Annual Meeting scheduled for August 10, 2026.
- Stockholder proposal deadline set for June 25, 2026 under Rule 14a-8.
- Filing contains no financial data, guidance, or material corporate events.
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-025121 |
| Document: 0001140361-26-025121-index-headers.html | 0001140361-26-025121 |
| Document: 0001140361-26-025121-index.html | 0001140361-26-025121 |
| Document: 0001140361-26-025121.txt | 0001140361-26-025121 |
Track record
28 reports on PDSB
7 of 14 bullish or bearish reports moved the stock their way by T+20. Best: +71.95% at T+20 after the Jul 22, 2026 report. 11 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
- Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
- Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
- Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
- Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
- Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
- Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers